113 related articles for article (PubMed ID: 9372614)
21. Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts.
Ris HB; Krueger T; Giger A; Lim CK; Stewart JC; Althaus U; Altermatt HJ
Br J Cancer; 1999 Mar; 79(7-8):1061-6. PubMed ID: 10098737
[TBL] [Abstract][Full Text] [Related]
22. Photothermal sensitization of amelanotic melanoma cells by Ni(II)-octabutoxy-naphthalocyanine.
Busetti A; Soncin M; Reddi E; Rodgers MA; Kenney ME; Jori G
J Photochem Photobiol B; 1999; 53(1-3):103-9. PubMed ID: 10672535
[TBL] [Abstract][Full Text] [Related]
23. Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model.
Chen B; de Witte PA
Cancer Lett; 2000 Mar; 150(1):111-7. PubMed ID: 10755394
[TBL] [Abstract][Full Text] [Related]
24. A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: in vitro and in vivo studies.
Jori G; Soncin M; Friso E; Vicente MG; Hao E; Miotto G; Colautti P; Moro D; Esposito J; Rosi G; Nava E; Sotti G; Fabris C
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S321-4. PubMed ID: 19376726
[TBL] [Abstract][Full Text] [Related]
25. Comparative pharmacokinetic and photodynamic studies with zinc(II) phthalocyanine in hamsters bearing an induced or transplanted rhabdomyosarcoma.
Shopova M; Mantareva V; Krastev K; Hadjiolov D; Milev A; Spirov K; Jori G; Ricchelli F
J Photochem Photobiol B; 1992 Oct; 16(1):83-9. PubMed ID: 1469513
[TBL] [Abstract][Full Text] [Related]
26. Effect of delivery system on the pharmacokinetics and tissue distribution of bis(di-isobutyl octadecylsiloxy)silicon 2,3-naphthalocyanine (isoBOSINC), a photosensitizer for tumor therapy.
Zuk MM; Rihter BD; Kenney ME; Rodgers MA; Kreimer-Birnbaum M
Photochem Photobiol; 1996 Jan; 63(1):132-40. PubMed ID: 8577866
[TBL] [Abstract][Full Text] [Related]
27. Tetra-n-propylporphycene as a tumour localizer: pharmacokinetic and phototherapeutic studies in mice.
Guardiano M; Biolo R; Jori G; Schaffner K
Cancer Lett; 1989 Jan; 44(1):1-6. PubMed ID: 2917338
[TBL] [Abstract][Full Text] [Related]
28. Tumour-localizing and -photosensitising properties of meso-tetra(4-nido-carboranylphenyl)porphyrin (H2TCP).
Fabris C; Vicente MG; Hao E; Friso E; Borsetto L; Jori G; Miotto G; Colautti P; Moro D; Esposito J; Ferretti A; Rossi CR; Nitti D; Sotti G; Soncin M
J Photochem Photobiol B; 2007 Dec; 89(2-3):131-8. PubMed ID: 17977739
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and photodynamic activities of silicon 2,3-naphthalocyanine derivatives.
Brasseur N; Nguyen TL; Langlois R; Ouellet R; Marengo S; Houde D; van Lier JE
J Med Chem; 1994 Feb; 37(3):415-20. PubMed ID: 8308868
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic therapy of ocular melanoma with bis silicon 2,3-naphthalocyanine in a rabbit model.
Hill RA; Reddi S; Kenney ME; Ryan J; Liaw LH; Garrett J; Shirk J; Cheng G; Krasieva T; Berns MW
Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2476-81. PubMed ID: 7591637
[TBL] [Abstract][Full Text] [Related]
31. Photothermal sensitisation as a novel therapeutic approach for tumours: studies at the cellular and animal level.
Camerin M; Rello S; Villanueva A; Ping X; Kenney ME; Rodgers MA; Jori G
Eur J Cancer; 2005 May; 41(8):1203-12. PubMed ID: 15911245
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor-mediated targeting of chlorin e6 selectively potentiates its photodynamic activity.
Gijsens A; Missiaen L; Merlevede W; de Witte P
Cancer Res; 2000 Apr; 60(8):2197-202. PubMed ID: 10786684
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic and tumour-photosensitizing properties of the cationic porphyrin meso-tetra(4N-methylpyridyl)porphine.
Villanueva A; Jori G
Cancer Lett; 1993 Sep; 73(1):59-64. PubMed ID: 8402599
[TBL] [Abstract][Full Text] [Related]
34. In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer.
Miller RA; Woodburn K; Fan Q; Renschler MF; Sessler JL; Koutcher JA
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):981-9. PubMed ID: 10571206
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity of different rat tumour strains to photodynamic treatment with chlorin e6.
Kostenich GA; Zhuravkin IN; Furmanchuk AV; Zhavrid EA
J Photochem Photobiol B; 1993 Feb; 17(2):187-94. PubMed ID: 8459320
[TBL] [Abstract][Full Text] [Related]
36. Static and ELF magnetic fields enhance the in vivo anti-tumor efficacy of cis-platin against lewis lung carcinoma, but not of cyclophosphamide against B16 melanotic melanoma.
Tofani S; Barone D; Berardelli M; Berno E; Cintorino M; Foglia L; Ossola P; Ronchetto F; Toso E; Eandi M
Pharmacol Res; 2003 Jul; 48(1):83-90. PubMed ID: 12770519
[TBL] [Abstract][Full Text] [Related]
37. Distribution of metal-free sulfonated phthalocyanine in subcutaneously transplanted murine tumors.
Karmakova T; Feofanov A; Nazarova A; Grichine A; Yakubovskaya R; Luk'yanets E; Maurizot JC; Vigny P
J Photochem Photobiol B; 2004 Jul; 75(1-2):81-7. PubMed ID: 15246354
[TBL] [Abstract][Full Text] [Related]
38. Photodynamic activity of chlorin e6 and chlorin e6 ethylenediamide in vitro and in vivo.
Gurinovich GP; Zorina TE; Melnov SB; Melnova NI; Gurinovich IF; Grubina LA; Sarzhevskaya MV; Cherenkevich SN
J Photochem Photobiol B; 1992 Apr; 13(1):51-7. PubMed ID: 1403368
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vivo activity of some porphyrindione derivatives with potential in photodynamic therapy.
Morgan AR; Garbo GM; Keck RW; Skalkos D; Selman SH
J Photochem Photobiol B; 1990 Jun; 6(1-2):133-41. PubMed ID: 2121930
[TBL] [Abstract][Full Text] [Related]
40. Treatment of pleural malignancies by photo-induction combined to systemic chemotherapy: Proof of concept on rodent lung tumors and feasibility study on porcine chest cavities.
Wang X; Gronchi F; Bensimon M; Mercier T; Decosterd LA; Wagnières G; Debefve E; Ris HB; Letovanec I; Peters S; Perentes JY
Lasers Surg Med; 2015 Dec; 47(10):807-16. PubMed ID: 26415084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
